Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|October 26, 2013
The influence of Pluronics nanovehicles on dark cytotoxicity, photocytotoxicity and localization of four model photosensitizers in cancer cellsJan Sobczyński, Solveig Kristensen, Kristian Berg
Drug Development and Industrial Pharmacy|July 17, 2014
Molecular interactions and solubilization of structurally related meso-porphyrin photosensitizers by amphiphilic block copolymers (Pluronics)Jan Sobczyński, Gro Smistad, Anne Bee Hegge, et al.
Nutrients|April 13, 2024
Nutritional Quality Implications: Exploring the Impact of a Fatty Acid-Rich Diet on Central Nervous System DevelopmentKatarzyna Smolińska, Aleksandra Szopa, Jan Sobczyński, et al.
International Journal of Molecular Sciences|February 13, 2026
Natural Bioactive Compounds Targeting FABP4 in Adipogenesis and Obesity: Evidence from In Vitro and In Vivo StudiesJan Sobczyński, Filip Nowaczyński, Katarzyna Smolińska, et al.
International Journal of Molecular Sciences|February 26, 2025
Zebrafish as a Suitable Model for Utilizing the Bioactivity of Coumarins and Coumarin-Based CompoundsJoanna Lachowicz-Radulska, Jarosław Widelski, Filip Nowaczyński, et al.
Progress in Lipid Research|September 11, 2025
Targeting fatty acid-binding protein 4: A therapeutic intersection of obesity and cancer via lipid metabolismKatarzyna Smolińska, Aleksandra Szopa, Piotr Dobrowolski, et al.
International Journal of Molecular Sciences|December 17, 2024
Effects of an Innovative High-Fat Diet on Intestinal Structure, Barrier Integrity, and Inflammation in a Zebrafish Model of Visceral ObesityKatarzyna Smolińska, Monika Hułas-Stasiak, Katarzyna Dobrowolska, et al.
Scientific Reports|February 6, 2024
Innovative high fat diet establishes a novel zebrafish model for the study of visceral obesityKatarzyna Smolińska, Jan Sobczyński, Aleksandra Szopa, et al.
Behavioural Brain Research|October 19, 2019
Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in miceEwa Poleszak, Sylwia Wośko, Karolina Sławińska, et al.
Pageof 1